
Join to view full profile
3351 El Camino RealSte 101Atherton, CA 94027
Phone+1 650-306-1016
Fax+1 650-369-3627
Dr. Bloch is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Blood Banking/Transfusion Medicine, 2008 - 2009
Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
University of Cape Town Faculty of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2007 - 2029
MD State Medical License 2015 - 2028
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016
Publications & Presentations
PubMed
- Infectious risks of transfusion: A 10-year look back and perspectives.Evan M Bloch, Steven J Drews, Jeremy W Jacobs
Transfusion Clinique Et Biologique. 2026-11-01 - Combined elevated C-reactive protein and detectable plasma RNA has predictive value for hospitalization during an outpatient COVID-19 convalescent plasma clinical trial.Yuriko Fukuta, Atika Singh, Jiangda Ou, Leilani Montalvo, Clara Di Germanio
Journal of Clinical Virology Plus. 2026-11-01 - How do we remediate blood banking/transfusion medicine fellows?Julie Katz Karp, Evelyn M Potochny, Annette J Schlueter, Nataliya Sostin, Jensyn Cone Sullivan
Transfusion. 2026-11-01
Journal Articles
- Risk Factors for Peripartum Blood Transfusion in South Africa: A Case‐Control StudyEvan Bloch, MD, Transfusion
Press Mentions
Convalescent Plasma Could Be Used as Early Treatment to Keep COVID Patients Out of HospitalDecember 21st, 2021
Study: Blood Plasma Given Early Reduces Risk for Hospitalization from COVID-19December 21st, 2021
Johns Hopkins Receives $35M in Federal Funding for COVID-19 Blood Plasma TrialsJuly 30th, 2020
Grant Support
- The Malaria Transfusion Risk (MATRix) StudyJOHNS HOPKINS UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: